|
AstraZeneca
opens new facility for TB research; Drug lead expected by 2006
THE Swedish pharma major AstraZeneca has accelerated its efforts
on finding new treatments for TB by opening up a new multi million
dollar discovery and research facility in Bangalore.
Eli
Lilly unveils global partnership to battle MDR TB
Eli Lilly and Company announced the launch of the first comprehensive
effort to fight the spread of multi-drug resistant tuberculosis
(MDR-TB), a serious international public health threat, particularly
in developing countries.
BACFO
secures world-class quality certifications
BACFO Pharmaceuticals (India) Ltd, a leading research-based ayurvedic
healthcare products manufacturer, has become the first company in
Asia to secure the most stringent international quality certifications.
News
Briefs
*Torrent Pharmas Q4 net drops
*NATCO Pharma launches Zoldonat
|